Skip to content

Michael Elliott Bigby, M.D.

NPI 1447201850ActiveIndividual· Dermatology· Boston, MA

Dermatology (M.D.) in Boston, Massachusetts, licensed in MA, with an NPI issued in May 2006. Part D covered 317 prescriptions written in 2024, 86% of them generic. Astrazeneca Pharmaceuticals LP reported $11,940 in payments in 2024, mostly consulting fees.

Overview

NPI1447201850
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorNo
NPI issuedMay 12, 2006
Last updated in NPPESJul 20, 2022
Certified by providerJul 20, 2022

Specialties and licenses

TaxonomyCodeLicenseState
Dermatology Primary207N00000X47598MA
Dermatology, Procedural Dermatology207NS0135X47598MA

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)317 · 425 30-day fills
Patients133
Total drug cost$310,558
Generic share86% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2024$11,940 · 1 payment from 1 company

Top paying companies in 2024

CompanyAmountPayments
Astrazeneca Pharmaceuticals LP$11,9401

What the 2024 payments were for

  • Consulting Fee$11,940 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other dermatologists in Boston

All 274 dermatologists in Boston · All dermatologists in Massachusetts